Funder: National Institutes of Health

Due Dates: September 7, 2025 | January 7, 2026 | May 7, 2026 | September 7, 2026 | January 7, 2027 | May 7, 2027 | September 7, 2027 | January 7, 2028 (AIDS - New/Renewal/Resubmission/Revision)

Funding Amounts: No budget cap; budgets must reflect actual needs. Project period up to 5 years.

Summary: Supports research to enhance recognition and elimination of HIV-1-infected cells by targeting cell surface HIV envelope, informing immunotherapy and vaccine development.

Key Information: Clinical trials are not allowed; foreign and domestic applicants are eligible.